European Continuing Education College



Similar documents
European Continuing Education College

Guide to Inspections of Tablet Manufacturing Facilities including Pre/Post Approval Issues as per USFDA

UNIVERSITY OF PARMA INTERDEPARTMENTAL CENTRE FOR INNOVATION IN HEALTH PRODUCTS, BIOPHARMANET-TEC

The importance of normalisation when comparing tablet properties

PHARMACEUTICAL EXCIPIENTS

Oral Solid Dosage Forms

PRODUCT DEVELOPMENT GUIDE

TABLET REFORMULATION CASE STUDY. Executive Summary

OOS investigations in a GMP environment

GUIDANCE NOTES TO COMPANIES ON HEARINGS BEFORE AND WRITTEN REPRESENTATIONS TO THE ADVISORY BOARD ON THE REGISTRATION OF HOMEOPATHIC PRODUCTS

How To Understand The Pharmacology Of The Pharmaceutical Industry

It is an important tool to assess factors that affect the bioavailability of a drug from a solid preparartion.

Fachgruppe Drug Delivery

Continuous Granulation and Drying

Main Conference Agenda

PHARMACEUTICAL DEVELOPMENT

Report of Step 3 event towards degree accreditation; Master of Pharmacy degree of the University of Sunderland, SEGi University College, May 2010

2Technical Support 3Formulation Development 4Proof of Concept 5 GMP Services 6Advanced Drug Delivery 1EUDRAGIT Products Evonik. Power to create.

STARCH Application Data

Report of Step 3 event towards degree accreditation; Master of Pharmacy degree of the University of Nottingham, Malaysia Campus, May 2007

11.I In-process control Authors: Dr. Christian Gausepohl / Paolomi Mukherji / Update 07

THE PHARMACEUTICAL INDUSTRY

Pharmaceutical Quality Systems: US Perspective

Vinod et al., ARPB, 2013; Vol 3 (II) ISSN

The Benefits of Tablet Tooling Standardization

QUALITY, SAFETY AND EFICACY ASSESSOR

SMART InTeRneT OF ThIngS

Extemporaneously Prepared Early Phase Clinical Trial Materials

Workshop B Control Strategy

Curriculum Vitae. Name: Alison Richardson, Clinical Professor of Cancer Nursing & End of Life Care

Guideline on dossier requirements for Type IA and IB notifications

Professor John Varcoe (Department of Chemistry, University of Surrey, UK) Plamen Atanassov

Guidance for Industry ANDAs: Stability Testing of Drug Substances and Products

Oil & Gas Talent Management Workshop

The identification of tablets and capsules containing barbiturates by MATR infrared spectroscopy

Simulation and Optimisation of a Pharmaceutical Production Line

Drug Delivery Systems III

Guidance for Industry

Updated on

Annex 6. Guidance on variations to a prequalified product dossier. Preface

Performance Evaluation of Actimask 92S Ibuprofen: A Novel Taste-Masked Ibuprofen for Use in Orally-Dispersible Dosage Forms

IHLM Certificate In Healthcare Operations Management

ICH Topic Q 1 A Stability Testing Guidelines: Stability Testing of New Drug Substances and Products

Oxford Asymmetry International plc 151 Milton Park Abingdon Oxon OX14 4SD United Kingdom Tel +44 (0) Fax +44 (0)

Journal of Chemical and Pharmaceutical Research

Annex 7 Guidelines on pre-approval inspections

Introduction to pharmaceutical technology

INTRODUCING THE NEW. Xcelodose S. New Powder Micro-dosing System. Even Faster Time to First in Man

Public Assessment Report Scientific discussion. Prednisolon Alternova (previous Prednisolon E Consult) (prednisolone) Asp no:

SPEAKER BIOGRAPHICAL INFORMATION

A Stability Program for the Distribution of Drug Products

Guideline on Process Validation

The Robert Gordon University The UK s s number 1 university for graduate employment. Source> The Sunday Times 2006

Academic Calendar for Faculty

Decommissioning of nuclear facilities

Uniformity of Dosage Units (BP 2011 & USP 34) Ms. Witinee Kongsuk Bureau of Drug and Narcotic Department of Medical Sciences June 14, 2011

Table 1. Pure superdisintegrant tablet formulation. Material % w/w Weight (mg) Superdisintegrant Stearic acid 1 2.

Guidance for Industry Tablet Scoring: Nomenclature, Labeling, and Data for Evaluation

GUIDELINES FOR RETENTION OF CLINICAL TRIAL RECORDS AT INVESTIGATOR STUDY SITES

COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP)

SPECIFICATIONS AND CONTROL TESTS ON THE FINISHED PRODUCT

Implementing virtual R&D reality in industry: In silico design and testing of solid dosage forms

Supply Chain Excellence

English Studies. CES Course Fees London Oxford Worthing Leeds Dublin. CES Dublin is an official IELTS Test Centre

Association of University Chief Security Officers -

Techniques of Tablet Coating: Concepts and Advancements: A Comprehensive Review.

Research needs in pharmaceutical excipients: implications of a global supply chain

Influence of the Changed USP Specifications on Disintegration Test Performance

OOT Forum Speakers: International Conference

supplement 18 PAYS D'ORIGINE NOM DOSAGE FORME NR ST LABORATOIRE 4ML CONCENTRATE FOR SOLUTION FOR INFUSION x 1VIAL

A masterclass in professional trading

ICH Topic Q4B Annex 5 Disintegration Test General Chapter. Step 3

20-21 May 2015, Lisbon, Portugal. Highlights. Speakers:

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN Review Article

Alharith Hassan. Q 10 Method of Shelf-life estimation. Methods of Chemical stabilisation 11/20/2015

Public Assessment Report. Scientific discussion. Calcium and Vitamine D3 Alpex 1000 mg/880 IE, effervescent granules

Manufacturing Services. Operational solutions for chemical, pharmaceutical, nutraceutical and cosmetic companies

MSc in Physics Research For students entering in 2006

Leadership for Drug Development Teams

Forensics Europe Expo 2015 Conference Programme

Solid dosage forms testing: Disintegration test and tablet friability and hardness

Troubled teens Recognising and responding to the health needs of looked after young people

Like-For-Like Changes: Is Validation Testing Needed? Validation Case Study #7

Method Development and Validation for Particle Size and Shape Measurements

Highly skilled Technical Consultant with first class knowledge in leading edge technologies used in the drug delivery device market.

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

QbD / PAT Conference 2014

Public Assessment Report Scientific discussion. Prednisolon Pilum (prednisolone) Asp no:

Salary Survey Domestic, International Salary Survey and Country Cost Analysis

ICH Topic Q 6 A Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances.

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP)

Invitation to Host Academy Event

ANNIVERSARY CELEBRATING TWO DECADES OF EXCELLENCE IN HAIR CARE GRANGE TOWER BRIDGE HOTEL, LONDON

outsourcing Solid dosage outsourcing: Mergers, expansions, and new technologies Matthew Knopp Editor

Small-Cell Lung Cancer Global Clinical Trials Review, H2, 2015

An integrated global healthcare company

6. Attendance Full-time Part-time Distance learning Mode of attendance No Yes N/A

Hallmarks of Cancer: Asia

Post-Approval Change Management: Challenges and Opportunities An FDA Perspective

Transcription:

Principles of Tablet and Capsule Formulation Three Day Intensive Course for Scientists, Managers and Technicians Holiday Inn Hotel, Oxford Circus, London, UK 12th, 13th and 14th October 2015 Course Background Tablets and capsules are the major dosage forms produced by the pharmaceutical industry. The formulation and evaluation of tablets and capsules is therefore an important area for many scientists and technicians working in the industry. The preparation of these solid dosage forms involves both a knowledge of the machinery on which they are made and an awareness of the physico-chemical and mechanical properties of the excipients which are available to formulators. In recent years, research into tabletting and capsule filling has led to a much greater understanding of the behaviour of materials during processing. Empirical formulation techniques can thus be supplemented with a more rational approach based on documented scientific evidence. Course Objectives The purpose of the Course is to provide a sound background to understanding the choices open to the formulator in designing tablet and capsule formulations. To achieve this, the course is taught by experienced practitioners to provide a blend of theory and practice. Who Should Attend The Course is designed as an introduction to the formulation of solid dosage forms. It is therefore intended for those who are new to the industry, whether in research, development, production or registration or those who have not previously been involved with solid dosage forms. The Course will also act as a useful refresher for those returning to the subject. Course Outline Basic Powder Technology An introduction to powder technology relevant to solid dosage forms. Particle size, flow, forces between particles. Preformulation Studies Preformulation studies (physico-mechanical, physico-chemical, biopharmaceutical) of solid dosage forms and application of such data in formulation development. Granulation and Drying Theory of granulation, fluid-bed granulators, high speed mixer granulators, comparison of methods, control of the process, granule properties. Drying theory, drying equipment, factors affecting drying. Compaction of Powders Theoretical and practical background to tablet production. The physics of tablet compression. Capping, lubrication and methods of assessing tabletting parameters.

Course Outline Mixing Theory and practice of mixing as an essential step in the production of tablets and capsules. Excipients Review of the excipients available, their properties and the rationale for selection. Current trends in excipients and formulation. Acceptability and registration problems, international harmonisation. Coating Coating processes, equipment, materials, solvents. Evaluation of Solid Dosage Forms Weight variation, content uniformity, disintegration, mechanical strength. Dissolution testing and its relevance in quality assurance and bioavailability. Quality by Design Current approaches to formulation strategy. Hard Gelatin Capsules Manufacture of capsule shells, filling machines, excipients, formulation. Liquid filled capsules. Drug release. Soft Gelatin Capsules Production, materials for filling, formulation, stability, bioavailability. Scale Up and Post Approval Changes (SUPAC) Sources of Information Case Studies Group discussions on specific problem cases arising in tablet and capsule formulations. Lecturers CHRIS MORETON B.Pharm., M.Sc., M.R.Pharm.S., Inst. Pkg (Dip)., Ph.D. (Course Director) Dr Moreton is an independent consultant and until recently was Vice President, Pharmaceutical Sciences at Idenix Pharmaceuticals, Cambridge, USA and was responsible for all formulation activities from preclinical safety studies through preformulation, formulation design and development, scale-up, clinical supply manufacture and technology transfer to the commercial manufacturing sites. Dr Moreton has over 25 years industrial experience at Pfizer Central Research, Sterling Winthrop R & D, ACO in Sweden and Genpharm in Canada. He also worked at Penwest (now JRS Pharma) both in the UK and the USA. At Penwest Pharmaceuticals he worked with excipients covering technical service and support, R & D and QA/QC for the drug delivery business. Dr Moreton is a member of the USP Excipient Monograph Content 2 Expert Working Group. He is a past Chairman of the IPEC-Americas (International Pharmaceutical Excipients Council of the Americas) and a member of the Drug Product Technical Committee (DPTC) of the Product Quality Research Institute (PQRI). Dr Moreton has special expertise in the formulation of solid dosage forms.

Lecturers BRIAN E. JONES M.Pharm., F.R.Pharm.S. Mr Jones has had over 35 years experience in all aspects of hard capsule production and encapsulation. He has developed an intimate knowledge of capsule formulation technology and has both technical and research interests in all aspects of the subject. He worked for Eli Lilly & Co. Ltd. for 29 years and assisted in the transfer of their capsule business to Shinogi Qualicaps. He is currently scientific advisor for Qualicaps, S.A. in Alcobendas, Spain and amongst his other activities, he is honorary lecturer at the Welsh School of Pharmacy, Cardiff University. GEORGE SMITH MSc., BSc., M.R.Pharm.S Mr Smith is Technical Sales Manager at Evonik Degussa and was previously Head of Process and Validation at Manesty. Prior to that he worked for R.P. Scherer and GlaxoSmithKline in solid dosage manufacture and development. He also worked for Colorcon in the design of film coating materials and equipment. In his position at Manesty he lead a team involved in equipment development, running customer trials, customer training, process research troubleshooting and optimization of the coating and compression processes on customer equipment. He has recently been awarded a master s degree at Manchester University investigating some of the factors involved in tablet film coating. PAUL BURTON C.Chem, M.R.S.C. Mr Burton has had extensive experience as a Formulation and Process Development Scientist with Beecham Products, Cyanamid UK and SmithKline Beecham Pharmaceuticals. He has been involved in new product introduction, scale-up of solid dosage forms and process validation. Currently he is Process Technology Manager for Glatt Protech where he has responsibility for applications of fluidised bed technology, high shear granulation and tablet coating technologies. ROYA PARKER Ph.D., B.Pharm., MRPharmS Dr Parker is Pharmaceutical Development Manager at Shire Pharmaceuticals and was previously Formulation Manager at Cardinal Health with over 15 years experience of development and manufacture of novel NCE, RX and OTC softgelatin capsule products. She is the British Pharmacopoeia nominated UK member of the gelatin working party at the European Pharmacopoeia Commission. FRIDRUM PODCZECK PhD, Dr Sc. Nat.Habil Professor Podczeck s research interests are in pharmaceutical engineering, particularly powder technology, oral solid dosage forms, fracture mechanics and the measurement and assessment of the role of inter-particulate forces of adhesion and friction in the performance of dosage forms such as dry powder inhalations, capsules, pellets and tablets. Professor Podczeck published her research in more than 150 peer-reviewed journal articles and she is the author of a book (Particle-particle Adhesion in Pharmaceutical Powder Handling, Imperial College Press, London, 1998), editor of a book (Pharmaceutical Capsules, Pharmaceutical Press, London, 2004 and several book chapters. Professor Podczeck is a member of the Editorial Board of the European Journal of Pharmaceutical Sciences, the International Journal of Pharmaceutics, the Journal of Pharmacy and Pharmacology, Pharmaceutical Technology Europe and Open Drug Delivery Journals (TODDJ, ODDR & ODDL). Her work in the area of Powder Technology won several prizes over the years, and in November 2004 she was awarded a Fellowship of the American Association of Pharmaceutical Scientists as a distinguished contributor and acknowledged leader in the advancement of the pharmaceutical sciences. In June 2006 Prof Podczeck was made an honorary member of the Royal Pharmaceutical Society of Great Britain in recognition of her work.

Fees and Registration The participation fee is 1595.00 (exclusive of VAT). Places are strictly limited and therefore applications will be accepted on a first come basis. Under UK law all applications are subject to Value Added Tax (VAT) irrespective of the country of origin of participants. Most VAT registered companies/organisations can reclaim this tax. The fee includes full personal participation, extensive bound course notes, luncheons and light refreshments, on all days of the Course. Dinner at night is not included. Cancellations cannot be accepted less than 14 days prior to the start of the Course, but substitutions may be made at any time. The Course language will be English. An approved Certificate of Attendance will be given to each participant at the end of the Course. Timing of The Course Registration will be at 8.45am on Monday 12th October and the Course will commence promptly at 9.00am. The Course will finish at about 17.00 on Wednesday 14th October. The Course will end at about 18.00 on each of the first two days.

ECEC - Registration Form Course - Principles of Tablet and Capsule Formulation Please fill in the following details to apply for a place. No payment is necessary now. When filling in the form, fields marked with an asterix (*) are compulsory. Your form will not be submitted if they are left blank. Personal Details First name: * Surname: * Organisation: Job title: Address: * Post/zip code: * Telephone no: Extension: Fax no: Email address: * I wish/do not wish to receive future mailings from ECEC about forthcoming courses. (Please note, we do not disclose your email address to any third party) Accommodation Accommodation will be at the: Holiday Inn Hotel, Oxford Circus, London, UK Room Rates: Single Room - Bed & Breakfast per person, per night 185.00 Twin Room - Bed & Breakfast per person, per night 220.00 Double Room - Bed & Breakfast per person, per night 220.00 Choose accommodation Type: I don t want accommodation I would like a Single Room - Bed & Breakfast I would like a Twin Room - Bed & Breakfast I would like a Double Room - Bed & Breakfast Choose which days: Sunday 11th October 2015 Monday 12th October 2015 Tuesday 13th October 2015 Wednesday 14th October 2015 Other nights (please specify): * Please note: Under UK law all applications are subject to Value Added Tax (VAT), irrespective of the country of origin of the Participant PLEASE FAX THIS COMPLETED FORM TO +44 (0)151 211 1860